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Summary
WHAT IS KNOWN ON THE SUBJECT? Red blood cell
transfusions are frequently used in the care of newborns,
particularly premature infants. Some countries have
guidelines regarding preparation, indication and adminis-
tration of red blood cells in newborns. There are no such
guidelines in Switzerland.
WHAT DOES THE CURRENT STUDY ADD? This study
analysed the results of two national surveys, one among
blood transfusion services and the other among neonatal
units in Switzerland. The results demonstrate consider-
able heterogeneity and a lack of “unité de doctrine”. Estab-
lishment of national guidelines would be helpful and war-
ranted.
AIMS OF THE STUDY: The aim of the study was to
analyse Swiss practices in blood transfusion services and
neonatal units for the preparation and administration of red
blood cells in newborns.
METHODS: Two questionnaires were developed and their
results analysed. A first questionnaire was developed for
the Swiss blood transfusion services and local hospital
haematology laboratories, and a second for the neonatal
units in Switzerland.
RESULTS: 18/25 (72%) of laboratories and 26/29 (90%) of
neonatal units performing red blood cell transfusions par-
ticipated. Responses revealed a lack of consensus for the
majority of questions. Differences were found in all steps
of the process, from preparation (testing, irradiation, split-
ting, shelf life and storage of blood bags) to indication and
administration (volume, speed, vascular access, patient
monitoring) of red blood cells. Forty-six percent of neona-
tal units stated that they apply internal guidelines. Never-
theless, all but two would welcome the establishment of
national recommendations.
CONCLUSION: This study confirmed the large variety in
neonatal red blood cell transfusion practices in Switzer-
land. In the absence of clear evidence, national guidelines
– as applied in other countries – would foster a common
policy among Swiss neonatologists and facilitate the im-
plementation of a national database for future research
and comparison with international literature.
Keywords: newborns, red blood cells, red blood cell
transfusion, blood transfusion services, guidelines
Introduction
Anaemia is a common problem in neonatal intensive care
[1]. Low erythropoietin levels and the necessity to take
frequent blood samples make premature infants particular-
ly vulnerable [1–3]. As a consequence, the vast majority
of extremely low birth weight infants (birth weight less
than 1000 g) require numerous red blood cell transfusions
(RBCTs) during their neonatal period [1, 2, 4–8].
Despite the frequent use of neonatal RBCT, there are few
guidelines in Switzerland addressing this issue. In addition,
there is a remarkable paucity of literature and, accordingly,
little evidence regarding the indication for RBCT in new-
borns. Many neonatologists use a particular haematocrit or
haemoglobin level to indicate RBCT. This level varies and
depends on the degree of prematurity, the postnatal age and
the clinical state of the baby, including oxygen requirement
and need for ventilatory support [8]. Apart from the ben-
eficial effects of RBCT for infants in neonatal intensive
care units, there is growing concern about adverse short-
term consequences of RBCT, particularly in very preterm
infants born before 32 weeks gestational age [4]. More-
over, recent studies suggest an association between trans-
fusion practices and later neurocognitive outcomes in these
tiniest infants [3, 5, 9, 10].
In addition, uncertainty remains with regard to the prepa-
ration and storage of blood products, transfusion volume
and rate, cardiorespiratory monitoring of patients and doc-
umentation of the intervention. Since sound evidence for
these issues is lacking, guidelines have been developed on
a national basis, for example in France [11], Germany [12],
the United Kingdom [13], Canada [5], Australia and New
Zealand [14].
In Switzerland, the Swiss Blood Transfusion Service
(BTS) of the Swiss Red Cross published mandatory guide-
lines for all 11 regional blood transfusion services (RBTSs)
Correspondence:
Prof. R. Arlettaz Mieth,
MD, Department of Neona-
tology, University Hospital
Zurich, Frauenklinikstrasse
10, CH-8091 Zurich, ro-
maine.arlettaz[at]usz.ch
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 1 of 7
to ensure standardisation of preparation, logistics and qual-
ity control of blood products (fig. 1) [15–17]. The RBTS
is the sole provider of blood components to hospitals su-
pervised by Swissmedic [18]. Some hospitals have an in-
house RBTS. In such cases, the RBTS is responsible for
the entire supply chain. In hospitals without an internal
RBTS, local haematology laboratories take responsibility
for certain processes such as storage and irradiation of
blood products. In contrast to the national standardised
processes adopted by the RBTSs, there are no guidelines
on irradiation, indication and administration of red blood
cells at the local level of hospital laboratories and neonatal
units. Therefore, we hypothesised that there is consistency
among BTSs, but no consensus among local laboratories
and Swiss neonatologists regarding blood transfusion prac-
tices in newborns.
Materials and methods
This was a cross-sectional study based on two question-
naires developed with a publicly available online tool for
surveys (findmind.ch). Full texts of both questionnaires are
provided in the appendices. The main focus was placed on
the neonatal survey.
PubMed was searched for neonatal literature and interna-
tional guidelines on red blood cell transfusion practices
and was restricted to publications in English. The search
was performed in April 2019 and updated in July 2019.
RAM and CR screened the literature and identified rele-
vant publications without prespecified in- and exclusion
criteria.
The study did not collect information on biological mate-
rial or medical personal data and does not fall within the
scope of human research law. Ethical approval was not re-
quired.
Swiss Blood Transfusion Services
In October 2016, the first questionnaire was sent to the 9
BTSs and 16 hospital laboratories in Switzerland respon-
sible for processing neonatal red blood cells, according to
the Swiss Red Cross guidelines (fig. 1) [17]. The question-
naire was developed with the help of the blood transfu-
sion unit of the University Hospital Zurich to reflect the
guidelines of the Swiss BTS [15, 16] and included 30 ques-
tions (appendix 1). For data conformity, all RBTSs were
asked to provide a list of neonatal units they prepare and
provide red blood cells for. All data were recorded and
stored anonymously. The BTSs and hospital laboratories
Figure 1: Blood transfusion services in Switzerland (data from the
Swiss Red Cross). The white spots symbolise the inter-regional
Blood Transfusion Services between three Swiss districts.
answered the questionnaire between October and Decem-
ber 2016.
Swiss neonatal units
The second questionnaire was sent in April 2016 to all lev-
el II and level III neonatal units accredited by the Com-
mittee for the Accreditation of Neonatal Units (CANU) of
the Swiss Neonatal Society, endorsed by the FMH [19, 20].
According to CANU, level III units include a neonatal in-
tensive care unit. Level II units provide intermediate care
and use noninvasive respiratory support with (level IIB)
or without (level IIA) continuous positive airway pressure
support. In addition, two paediatric intensive care units and
five neonatal units not yet accredited by CANU were con-
tacted. Thus, a total of 34 units were invited to participate
– 10 level III perinatal centres, 17 level II neonatal units, 2
paediatric intensive care units and 5 with pending CANU
classification. The questionnaire, developed by neonatol-
ogists (RAM, CR) was sent to the medical head of each
unit and consisted of twelve questions related to the unit’s
blood transfusion practices in the treatment of newborns
(appendix 2). Moreover, participants were asked to pro-
vide a copy of their local blood transfusion guidelines, if
they had any. No centre was excluded from the survey. The
neonatal units answered the questionnaire between April
and December 2016.
One investigator (GL) sent the surveys, collected all data
and performed descriptive analysis of the results under the
supervision, control and responsibility of RAM and CR.
Results
Results from the Swiss blood transfusion services
Eighteen (72%) of the 25 RBTSs and laboratories an-
swered the survey questions. All but three (88%) followed
the guidelines of the BTS and Swiss Red Cross. The ma-
jority of laboratories (14/17) prepare full pouches of about
350–400 ml and nearly the same number (13/17) also de-
liver split pouches of 60–80 ml each, depending on avail-
ability. Irradiation procedures of blood products differed
from one centre to the other: 2/15 (13%) do not irradiate
at all, 4/15 (27%) irradiate blood for all newborn infants
and 9/15 (60%) irradiate blood for premature infants only,
although the gestational age limits range from 24 to 37
weeks. In 15/17 (88%) responding RBTS and laboratories,
blood bags are shared locally. Storage times range from
5 to 49 days (median 28 days; fig. 2). Determination of
the newborn’s blood group before RBCT is mandatory and
is performed on a blood sample from the baby (16/16,
100%), but also on umbilical blood (6/16, 38%). Nine out
of 16 (56%) laboratories deliver blood bags with O nega-
tive red blood cells, whereas the remaining laboratories (7/
16, 44%) provide red blood cells compatible with the blood
group of the mother, the baby or both. In that case, com-
patibility is tested for the first RBCT only.
Results from the Swiss neonatal units
Five out of 34 neonatal units (15%) do not transfuse red
blood cells. These five units are small and rarely encounter
situations where transfusions are required; this makes re-
ferral to a larger centre reasonable if a transfusion is indi-
cated. Twenty-six (90%) of the remaining 29 units partici-
pated in the survey.
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The cantons of Zurich and Vaud are most strongly repre-
sented, with five (19%) neonatal units each. Sixteen (62%)
neonatal units purchase blood products from local haema-
tology laboratories, ten (38%) units order from RBTS. All
neonatal units document the patient’s vital parameters be-
fore and during RBCT, but there are differences in ap-
proach, ranging from pulse oximetry alone to combined
monitoring of pulse oximetry, heart rate and blood pres-
sure. Twenty-four (92%) units noted that they would check
the haematocrit or haemoglobin level between 30 minutes
to several hours after the end of the transfusion.
Units use various transfusion volumes; six (23%) neonatal
units transfuse 10 ml/kg, another six (23%) transfuse 15
ml/kg and five (19%) transfuse 20 ml/kg. The remaining
nine (35%) neonatal units reported various blood volumes
for RBCT, usually ranging from 10 to 20 ml/kg. Partici-
pants reported the main determinants for transfusion vol-
ume to be haematocrit or haemoglobin levels prior to trans-
fusion, differentiation between acute and chronic anaemia,
clinical state of the baby, concomitant pathologies such as
bronchopulmonary dysplasia or congenital heart disease,
and importantly, the neonatologist in charge.
Transfusion rates for red blood cells vary; 11 (44%) units
transfuse at a rate of 5 ml/kg/h, 7 (28%) units use 2–4 ml/
kg/h and 5 (20%) units 10 ml/kg/h. Two (8%) neonatal
units use individual transfusion rates based on the clinical
indication. Some participants reported a transfusion break
of one hour in the middle of the RBCT.
A number of vascular access sites are used for RBCT; red
blood cells are given through a peripheral venous catheter
in all 26 (100%) units, through an umbilical venous
catheter in 20 (77%) units, a central venous catheter in 9
(35%) units, and an umbilical arterial catheter in 5 (19%)
units.
Local guidelines in Swiss neonatal units
Twelve of the 26 (46%) participating neonatal units, in-
cluding all level III perinatal centres, apply local guidelines
for RBCT. The units without internal guidelines either fol-
low those of their reference level III centres or consider the
clinical aspect of the baby to indicate RBCT.
Discussion
The present study shows little agreement in RBCT prac-
tices among local laboratories and neonatal units. In con-
trast to our hypothesis, we also found some variability
Figure 2: Maximum shelf life of red blood cells: X axis is days (d),
Y axis is the percentage of participants providing this response.
in the preparation and logistics of blood products among
RBTSs, despite the implementation of national guidelines.
These findings may be explained by a lack of evidence for
both the supply chain of red blood cells at the regional lev-
el and transfusion practices at the local hospitals.
In the following section, we discuss and compare our find-
ings with national guidelines of other countries in Europe,
North America and Australia/New Zealand and the avail-
able literature for the five main topics (practices for red
blood cell preparation and storage, transfusion threshold,
transfusion volume, transfusion rate, and vascular access)
[5, 11–14].
Preparation and storage of red blood cells
In Switzerland, volumes of split products are dependent
on the initial standard product volume. Therefore a four-
pouch single unit has a volume of 60–80 ml and a two-
pouch single unit a volume of 120–160 ml. One of the
present study’s aims was to document the practices in the
RBTSs and local laboratories for preparation and storage
of blood products for newborns, in particular with regard
to irradiation procedures and storage of red blood cells.
Since RBTSs claim to follow the guidelines of the Swiss
Red Cross [15, 16], we were surprised to find differences
among laboratories.
The Swiss Red Cross recommends irradiating blood prod-
ucts that will be administered to premature infants. Given
that preterm infants are immature and have some degree of
immunological incompetency, irradiated blood could pro-
tect this fragile population from blood-related immunolog-
ical complications. This recommendation is followed in-
constantly by the RBTSs, as demonstrated by the various
indications reported by participants for blood product irra-
diation in Switzerland. Indeed, there is no evidence for a
clear benefit of irradiating blood. The British and French
haematology societies recommend irradiating blood trans-
fused to newborns who were exposed to intrauterine trans-
fusions, who need exchange or massive transfusions, or
who have an inherited cellular immunodeficiency [11, 21].
It may be argued that extremely premature infants are
immunocompromised, which may be the reason why the
Australian and New Zealand guidelines suggest a gesta-
tional age below 28 weeks and a birth weight below 900
g as indications for blood irradiation [14]. However, red
blood cell bags transfused to newborns are leucocyte de-
pleted, mainly to avoid transmission of cytomegalovirus.
The almost complete absence of viable lymphocytes in
transfused blood units makes the probability of transfu-
sion-associated graft versus host disease negligible for
most patients, except for those suffering from hereditary
or acquired immunodeficiencies. Further, irradiation leads
to a reduced shelf life of the red blood cells. There was
only partial consensus on this aspect and no clear recom-
mendations among members of the European Committee
on Blood Transfusion in their “Guide to the preparation,
use and quality assurance of blood components” published
in 2015 [22].
How long may red blood cells be stored before trans-
fusion? In the present study, storage times ranged from
5 to 49 days (median 28 days; see fig. 2). Again, very
little evidence means there is a lack of consensus. In the
French guidelines, storage time varies, depending on sev-
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eral parameters such as gestational age, birth weight, clin-
ical state and transfusion volume. The Swiss BTS and the
British guidelines recommend a maximum storage time of
35 days. The Canadian, USA, Australian and New Zealand
guidelines extend the shelf life to 42 days [11, 16, 21, 23,
24]. In a randomised controlled trial including 377 prema-
ture infants with a birth weight of less than 1250 g, Fergus-
son et al. did not demonstrate a negative effect of a long
(up to 42 days) versus a short (less than 7 days) storage
time on mortality or acute organ failure [10]. No evidence
exists to justify a red blood cell storage time of more than
42 days.
Transfusion threshold
The present study shows that a minority of Swiss neonatal
units have guidelines on transfusion thresholds, but vari-
ability from one centre to another is high. Thus, compari-
son with the international literature is of great interest and,
not surprisingly, there is little consensus across the world.
Recent literature emphasises that RBCTs are not purely
beneficial for the newborn infant. They also carry the risk
of adverse effects, including an increase in mortality and
morbidities such as necrotising enterocolitis, retinopathy
of prematurity or long-term neurodevelopmental impair-
ment [3, 8–10, 25–27]. Thus, a cautious restrictive strategy
seems appropriate.
The British Committee for Standards in Haematology pub-
lished guidelines in 2016 with a restrictive RBCT policy
[13]. The thresholds depend on the postnatal age and the
need for respiratory support. Guidelines from Australia
and New Zealand consider – apart from postnatal age and
the need for oxygen or respiratory support – individual
clinical factors, such as severity of illness, anticipated
blood loss, quality of nutrition and site of sampling [14].
Germany also takes a restrictive stance [12]. France adopt-
ed transfusion policies based on haematocrit or haemo-
globin levels and a number of clinical and laboratory pa-
rameters [11]. Howarth et al. summarised the major
international practice guidelines on RBCT in newborns
[8].
In 2011, Whyte and Kirpalani published a Cochrane Re-
view on low versus high haemoglobin thresholds for blood
transfusion for preventing morbidity and mortality in very
low birth weight infants [28]. Four trials could be included;
they did not show an impact of the transfusion threshold on
mortality and serious morbidity. A single trial of this sys-
tematic review reported no difference in the neurodevelop-
mental outcome at 18 to 21 months between the low and
high RBCT threshold groups [26, 27]. The authors con-
cluded that further trials would be required to define the
impact of transfusion practices on long-term outcome. The
results of two large randomised controlled trials evaluating
the effects of transfusion thresholds (liberal versus restric-
tive) on neurodevelopment of very preterm infants are ea-
gerly awaited (ETTNO and TOP Trial [4, 29]).
To some extent, the variability in transfusion thresholds
seen in national guidelines and the literature may be ex-
plained by the number of clinical variables considered be-
fore transfusing a newborn infant, such as postnatal age or
need for respiratory support [2, 8].
Transfusion volume
The blood volume transfused to a newborn infant is of
great importance, particularly in the extremely premature
infant. A low volume can expose the baby to more transfu-
sions, whereas a high volume can lead to cardiopulmonary
deterioration due to volume overload. In addition, high
transfusion volumes will slow down erythropoiesis. In the
present survey, commonly transfused red blood cell vol-
umes ranged from 10 to 20 ml/kg. Some units also take
further criteria into consideration, such as the haemoglo-
bin level or the weight of the baby. In the literature, trans-
fusion volumes between 10 and 20 ml/kg are most fre-
quently found. The French guidelines recommend 15 ml/
kg in premature infants born before 32 weeks of gestation
or with a birth weight below 1500 g, and 20 ml/kg for older
and heavier babies [11]. Canada, France and the UK rec-
ommend 10 to 20 ml/kg [5, 11, 21]. In a randomised pi-
lot study in infants with a birth weight of less than 1500
g, Paul et al. compared a transfusion volume of 10 ml/kg
with 20 ml/kg and found that the transfusion of 20 ml/kg
red blood cells produced a significantly greater increase in
haemoglobin and haematocrit levels than a transfusion of
10ml/kg, without detrimental effects on pulmonary com-
pliance and resistance [6]. Von Lindern et al. analysed the
long-term outcome of extremely premature infants receiv-
ing either 15 or 20 ml/kg red blood cells. Again, no sig-
nificant difference in neurodevelopment was observed [9].
However, in the case of severe anaemia or hypovolaemic
shock, higher RBCT volumes may be required. Close mon-
itoring of these patients is essential in order to avoid trans-
fusion-associated circulatory overload or heart failure [21].
In summary, current evidence does not provide a definite
volume recommendation; however, the majority of authors
recommend an upper limit of 15 ml/kg in order to avoid
volume overload.
Transfusion rate
Apart from the transfusion volume, the transfusion rate is
of interest. Again, a baby with a compromised cardiopul-
monary situation may benefit from a low rate. However, a
higher transfusion rate may allow the use of a single blood
bag within the maximum time allowed. In our survey, we
found RBCT rates between 2 and 10 ml/kg per hour. The
rate should be higher in acute situations such as hypo-
volaemic shock [5]. Some units do not have guidelines
and, again, neonatologists seem to determine the transfu-
sion rates based on the age of the baby, the haematocrit or
haemoglobin levels and the clinical condition. Venkatesh
et al. found no differences between transfusion times of
3 versus 12 hours with regard to intraventricular haemor-
rhage, necrotising enterocolitis and nosocomial infections
[25]. However, both transfusion rates used in this study
may be too low for the chosen outcomes.
The consensus in international guidelines is to transfuse at
a rate of 5 ml/kg per hour [11, 14, 21]. However, this rec-
ommendation is empirical and not evidence based.
Vascular access
All neonatal units in our survey use intravenous peripheral
lines as vascular access for RBCT. However, RBCTs are
also given through venous and arterial umbilical catheters,
and central venous catheters. A separate peripheral line
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is the ideal intravenous access, allowing slow transfusion
rates and preventing infection [13]. However, in the ex-
tremely premature newborns or those in a poor medical
condition, inserting a peripheral intravenous cannula may
be difficult. There is a complete lack of literature on the
preferred vascular access for RBCT. If central venous or
even arterial access is used for RBCT, inherent risks in-
cluding infections, thrombosis or clotting of the catheter
must be considered. For compatibility and osmolality rea-
sons, no parallel solution should be infused during the
RBCT [13]. Every vascular access for RBCT must be
documented. In addition, adverse reactions to transfusions
have to be reported to the national “haemovigilance sys-
tem” as advised by Stainsby on behalf of the Serious Haz-
ards of Transfusion (SHOT) steering group [30].
Strengths and limitations
The strength of the present study is the high participation
rate, particularly among neonatologists. Ninety percent of
the neonatal units – reflecting 98% of newborns in
Switzerland – responded to the questionnaire, which
makes our results representative for the whole neonatal
population. The main limitations include the fact that some
questions were only partially answered and that answers to
an online questionnaire usually reflect the opinion of the
participant and are not necessarily representative of every-
day practice at that establishment.
Conclusion
In conclusion, there is a lack of consensus on various as-
pects of red blood cell transfusion in neonatal units in
Switzerland and wide variability in practice. A paucity of
evidence, particularly regarding haemoglobin transfusion
thresholds, explains the diversity in local guidelines and
illustrates the need for further studies. Conscious of the
various practices around RBCT at regional and local lev-
els, we would welcome the development of Swiss-wide
recommendations, particularly in the absence of good ev-
idence. This would foster a “unité de doctrine” among
Swiss neonatologists and support the establishment of a
national database enabling the development of studies and
comparison with international literature. Our sentiment is
shared by the neonatology community, with all but two
Swiss neonatal units stating that they would welcome
Swiss RBCT guidelines.
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Appendix 1
Questionnaire sent to the blood transfusions
services and hospital laboratories
Appendix 2
Questionnaire sent to the neonatal units
The questionnaires are available in separate files at:
https://smw.ch/article/doi/smw.2020.20178.
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